ZPHC Pre-Filled Pen Premixed Aqueous
SpecsBuy ZPHC Retatrutide AQ 30mg / 3mL Pen in Dubai
Triple-receptor agonist tested in phase 3 trials
AED 1,440 / pen
- Quantity
- 30mg in 3mL
- Format
- Premixed aqueous pen
- Pack size
- 1 pen (3mL)
- Purity
- 99%+
Choose your bundle
Free UAE delivery on this order
- OrderBefore 4 PM for Dubai
- PackedCold-chain, 2–8°C
- DeliveredSame day in Dubai, next day elsewhere in the UAE
Order before 4 PM for same-day Dubai delivery.
UAE delivery: AED 50 below AED 1,000; free from AED 1,000
Pay byCard payment linkUSDT
99%+ purityIn-house tested
- Sold by
- Remy Research
- Brand
- ZPHC
- Manufacturer
- ZPHC
- Tested by
- 99%+ line standard
- 99%+ purityLine standard
- Same-day DubaiOrder before 4 PM for same-day delivery
- FormatPremixed aqueous pen
- Cold-chain packed2–8°C
ZPHC Retatrutide 30mg AQ Pen: What the Research Shows
- 25.0% average weight loss in 80 weeks
- 1.94% average HbA1c drop in 40 weeks
- 82.4% average liver-fat reduction in 24 weeks
Published study results for the compound, not results from this product. For research use only.
If you're searching for the zphc retatrutide 30mg aq pen, this page refers to the premixed aqueous ZPHC pen supplied as one pre-filled pen containing 30mg of Retatrutide in a 3mL cartridge. It is written for researchers and professionals sourcing Retatrutide in the UAE, especially those comparing premixed peptide formats with lyophilized vial kits or the 60mg dual-chamber pen that keeps powder and sterile water separate until activation.
Along with the core product specs, you'll find the key details that matter before ordering or handling it: format, pack size, storage guidance, what is included, how it compares with other Retatrutide options, and why Retatrutide continues to draw research attention for its reported effects on weight loss, blood sugar, and liver fat in clinical study settings. Retatrutide (LY3437943) is an investigational compound developed by Eli Lilly that acts on the GIP, GLP-1 and glucagon receptors, and this pen is supplied for laboratory and research use only, not for human or veterinary use.
- Pack Size
- 1 pen (3mL)
- Same-Day Delivery
- Dubai
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
- 1 ZPHC Retatrutide AQ pen containing 30mg in 3mL
- ZPHC retail packaging
Other formats of Retatrutide
Ships from Dubai
ZPHC Retatrutide
From AED 21.25 / mg
In-stock options ship from our Dubai stock. All products
What does AQ mean on this pen?
AQ means the contents come in a premixed aqueous format, and it should be stored between 2°C and 8 °C. This pen contains 30mg total in a 3mL cartridge.
Choose this product if you want the premixed ZPHC pen. Keep it refrigerated in the original packaging to protect it from direct light and excessive heat. The 60mg dual-chamber pen is different: its powder and sterile water stay separate until activation.
This listing contains one pen, not a five-vial kit. The vial kits are shown as separate products. Do not freeze the pen. The AQ pen is a distinct format from our vial range. For clarity on the difference, retatrutide is also available in separate 10, 15, 20, 40, 60 and 120 mg ZPHC vial formats (one single vial and five-vial kits), each listed as its own catalog item.
Why Buy Retatrutide AQ 30mg / 3mL for weight management research from Remy Research?
Premixed AQ format.
The 30mg contents of this ZPHC Reta 30mg pen come premixed in a 3mL pen format rather than as lyophilized powder.
One pen, 30mg total.
You receive one ZPHC AQ pen in its retail box, clearly separated from the multi-vial kits.
One-device pen format.
You receive one premixed pen rather than several separate vials.
Chemistry · Reference dataRetatrutide chemistry & specifications
Identity
Peptide agonist of GIP, GLP-1 and glucagon receptors, combining three receptor systems
Retatrutide (LY3437943)
Also known asReta, LY3437943, LY-3437943
- CAS
- 2381089-83-2
Molecule
- Formula
- C221
H342 N46 O68 - Molecular weight
- 4,731 g/mol Registry value for the peptide without counter-ions; not measured for this batch.
- Sequence
- Note
- Retatrutide (LY3437943) is studied for obesity, type 2 diabetes, and metabolic liver disease, with researchers investigating whether combining these pathways may produce broader metabolic effects than single-pathway compounds.
- Note
- Published research and clinical trials assess Retatrutide’s effects on body weight, with observations tied to the body and study periods of 48 weeks (Phase 2) and 80 weeks (Phase 3 TRIUMPH-1).
This product for research use
- Manufacturer
- ZPHC
- Product code
- ZRT30P
- Pack size
- 1 pen
- Total amount
- 30mg
- Fill volume
- 3mL
- Format
- Premixed aqueous pen
- Dispatch
- Remy Research sends this product across the UAE to support local supply needs: Dubai orders placed before 4 PM arrive the same day, and orders elsewhere placed before 12 PM (noon) arrive the next day.
- Note
- Transfer Retatrutide to monitored laboratory storage upon receipt.
Batch documentation
99%+ line standard
Every report we have published is listed in the lab results library.
Reference data for laboratory checks. Registry values describe the compound, not measurements of this batch. For research use only.
For research purposes only. Not for human consumption.
Frequently Asked Questions
Is the ZPHC 30mg AQ pen premixed?
Yes. It is a premixed aqueous pen containing 30mg in a 3mL cartridge.
What adverse effects have been reported in trials?
Reported clinical-trial adverse effects include nausea, vomiting, diarrhea, and constipation.
Were any other trial effects noted?
Trials also reported temporary skin sensitivity and increased heart rate during treatment.
Are there serious risks discussed in studies?
Potential serious risks studied in trials include pancreatitis and gallbladder disease, which carry class warnings on approved GLP-1-based medicines; the Phase 2 trial reported one adjudicated case of acute pancreatitis among 267 retatrutide participants (none among 70 on placebo), and TRIUMPH-1 reported gastrointestinal events as the most common adverse events.
Is this the same as the 60mg dual-chamber pen?
No. The 30mg AQ pen is premixed. The 60mg dual-chamber pen holds lyophilized material and sterile water in separate chambers until activation.
Does the 30mg AQ product include vials?
No. This listing contains one premixed 30mg AQ pen. The ZPHC vial kits are separate products.
What are the chemical identifiers of Retatrutide?
Retatrutide (LY3437943) has CAS number 2381089-83-2, molecular formula C221H342N46O68, molecular weight 4,731 g/mol, PubChem CID 171390338. These are registry values for the compound, not measurements of a batch.
Where can I buy the ZPHC Retatrutide 30mg pen in Dubai?
Remy Research sells the ZPHC Retatrutide AQ 30mg / 3mL pen online at AED 1,440 for laboratory research use only. Order through website checkout. Dubai orders placed before 4 PM arrive the same day. Other emirates get next-day delivery on orders placed before 12 PM (noon). Parcels are cold-chain packed at 2 to 8°C.
Can I buy the ZPHC Retatrutide AQ 30mg pen for weight loss?
The ZPHC Retatrutide AQ 30mg pen is one premixed aqueous pen with 30mg in a 3mL cartridge, listed at AED 1,440 for laboratory research only. It is not for human consumption. As retatrutide remains an investigational compound with no FDA approval, the shop declines to advise on personal use. Trial results on the page speak about the compound, not about this item.
Is there a shop where I can buy the ZPHC Retatrutide AQ 30mg pen near me in Dubai?
For the ZPHC Retatrutide AQ 30mg pen, use the website: the shop has no walk-in location. At AED 1,440, it ships by cold-chain courier to every emirate, with same-day arrival for Dubai orders before 4 PM. It is supplied for laboratory research use only.
Can I buy the ZPHC Retatrutide AQ 30mg pen for research in the UAE?
AED 1,440 buys the ZPHC Retatrutide AQ 30mg pen, which is a premixed aqueous pen filled with 30mg in 3mL. Orders for laboratory research are accepted in the UAE, and human consumption is not the purpose. Retatrutide stays investigational and unapproved by the FDA. Delivery uses a cold-chain route to the seven emirates.
Is GLP-3 RT the same as retatrutide?
Yes. Some sellers list retatrutide (LY-3437943) as GLP-3 or GLP-3 RT. That is a nickname, not a separate compound or drug class: retatrutide acts on the GIP, GLP-1 and glucagon receptors, and there is no GLP-3 hormone. This pen contains retatrutide and is supplied for laboratory research use only.


